1
|
Yi M, Liao Z, Deng L, Xu L, Tan Y, Liu K, Chen Z, Zhang Y. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer. Ann Med 2021; 53:2178-2193. [PMID: 34913774 PMCID: PMC8740622 DOI: 10.1080/07853890.2021.2000634] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Accepted: 10/26/2021] [Indexed: 12/24/2022] Open
Abstract
BACKGROUND MicroRNAs (miRNAs) are good candidates as biomarkers for Lung cancer (LC). The aim of this article is to figure out the diagnostic value of both single and combined miRNAs in LC. METHODS Normative meta-analysis was conducted based on PRISMA. We assessed the diagnostic value by calculating the combined sensitivity (Sen), specificity (Spe), positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic odds ratio (DOR) and the area under the curve (AUC) of single and combined miRNAs for LC and specific subgroups. RESULTS A total of 80 qualified studies with a total of 8971 patients and 10758 controls were included. In non-small cell lung carcinoma (NSCLC), we involved 20 single-miRNAs and found their Sen, Spe and AUC ranged from 0.52-0.81, 0.66-0.88, and 0.68-0.90, respectively, specially, miR-19 with the maximum Sen, miR-20 and miR-10 with the highest Spe as well as miR-17 with the maximum AUC. Additionally, we detected miR-21 with the maximum Sen of 0.74 [95%CI: 0.62-0.83], miR-146 with the maximum Spe and AUC of 0.93 [95%CI: 0.79-0.98] and 0.89 [95%CI: 0.86-0.92] for early-stage NSCLC. We also identified the diagnostic power of available panel (miR-210, miR-31 and miR-21) for NSCLC with satisfying Sen, Spe and AUC of 0.82 [95%CI: 0.78-0.84], 0.87 [95%CI: 0.84-0.89] and 0.91 [95%CI: 0.88-0.93], and furtherly constructed 2 models for better diagnosis. CONCLUSIONS We identified several single miRNAs and combined groups with high diagnostic power for NSCLC through pooled quantitative analysis, which shows that specific miRNAs are good biomarker candidates for NSCLC and further researches needed.
Collapse
Affiliation(s)
- Minhan Yi
- Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China
- School of Life Sciences, Central South University, Changsha, Hunan, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Zexi Liao
- Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Xiangya Medical School, Central South University, Changsha, Hunan, China
| | - Langmei Deng
- Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Emergency, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Li Xu
- Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China
- School of Life Sciences, Central South University, Changsha, Hunan, China
| | - Yun Tan
- School of Life Sciences, Central South University, Changsha, Hunan, China
| | - Kun Liu
- School of Life Sciences, Central South University, Changsha, Hunan, China
| | - Ziliang Chen
- School of Computer Science and Engineering, Central South University, Changsha, Hunan, China
| | - Yuan Zhang
- Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China
| |
Collapse
|
2
|
Coleman R, Driver M, Gishen P. Percutaneous lung biopsy: experiences during the first 54 biopsies. Cardiovasc Intervent Radiol 1982; 5:61-3. [PMID: 7105076 DOI: 10.1007/bf02552078] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
The first 54 consecutive percutaneous aspiration biopsies of pulmonary lesions of an ongoing prospective trial performed in this hospital between July 1977 and March 1980 have been evaluated. The technique was found to be safe and provided a reliable and rapid diagnosis. An overall diagnostic accuracy of 83% was achieved. In malignant lesions a correct diagnosis was made in 85% of biopsies. These results are compared with other workers using the same technique and with fiberoptic bronchoscopy and sputum cytology. Aspiration is recommended as an excellent alternative to other more established techniques, particularly in the diagnosis of the peripheral lesion.
Collapse
|
3
|
Abstract
All patients attending the Austin Hospital, Melbourne, with the diagnosis of carcinoma of the lung in the two year period 1974 to 1975 were reviewed. There 211 patients in the series, comprising 1.2% of all patients admitted to hospital, and the methods of diagnosis and management were reviewed. Squamous and anaplastic carcinomata were equally frequent, comprising 75% of all cases, and there was a significantly lower incidence of squamous cell carcinoma in females (6.3%) compared with other cell types (20% to 30%). Sputum cytology was the most rewarding single source of tissue diagnosis, and bronchoscopy and mediastinoscopy next most helpful. Only 25% of the patients were fit for surgical treatment, and only 20% of the carcinomata were able to be resected.
Collapse
|